Copertina

Expanding the Toolbox With Non‐Factor Therapies

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autore principale:	Maria Elisa Mancuso
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Haemophilia
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The haemophilia joint health score for the assessment of joint health in patients with haemophilia
di: Cihan Ay, et al.
Pubblicazione: (2024)

Pathogenesis of osteoarthritis, rheumatoid arthritis, and hemophilic arthropathy: The role of angiogenesis
di: Laura Caliogna, et al.
Pubblicazione: (2024)

Utilising Thrombin Generation Assay to Guide Co‐Administration of Factor Therapies With Fitusiran
di: Yesim Dargaud, et al.
Pubblicazione: (2025)

UKNEQAS Blood Coagulation Factor Nine (FIX) Gene Therapy Supplementary Exercise 2025
di: Christopher Reilly‐Stitt, et al.
Pubblicazione: (2025)

Thrombin Generation in Pediatric Haemophilia A Patients on Extended Half‐Life FVIII versus Non‐FVIII Therapies
di: Jessica Garcia, et al.
Pubblicazione: (2026)

Evaluation of One‐Stage Assays for the Monitoring of Recombinant Human Factor IX Padua Activity After Etranacogene Dezaparvovec Gene Therapy
di: Jan Astermark, et al.
Pubblicazione: (2025)

Extension Study With rVIII‐SingleChain in Previously Untreated Patients (PUPs) With Severe Haemophilia A
di: Johnny Mahlangu, et al.
Pubblicazione: (2025)

Qualification Criteria of Gene Therapy for Haemophilia—Opinion of the EAHAD Gene Therapy Working Group
di: Wolfgang Miesbach, et al.
Pubblicazione: (2025)

Defining the Role of Nurses in Gene Therapy for Haemophilia
di: Greta Mulders, et al.
Pubblicazione: (2026)

Supporting Patient‐Centred Decisions on Gene Therapy for Haemophilia A: A Conceptual Model
di: Giovanni Di Minno, et al.
Pubblicazione: (2025)

Bringing Gene Therapy Into Real World Clinical Practice
di: Wolfgang Miesbach, et al.
Pubblicazione: (2026)

The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025
di: Glenn F. Pierce, et al.
Pubblicazione: (2025)

Factor X and Combined Factor VIIa/Factor X Augment Coagulation Potential in a Plasma Model of Tissue Factor Pathway Inhibitor‐Reduced Haemophilia State
di: Shigeharu Oh, et al.
Pubblicazione: (2026)

Systematic Literature Review of Outcomes Associated With Adherence to Haemophilia Drug Therapy
di: Cynthia Khanji, et al.
Pubblicazione: (2025)

Psychosocial Care During Novel Therapies in Haemophilia: A Psychological Framework
di: Lotte Haverman, et al.
Pubblicazione: (2025)

Adherence to Clotting Factor Prophylaxis in Adolescent and Adult Males With Haemophilia
di: Nathália Martins Beserra, et al.
Pubblicazione: (2026)

Considerations for the Use of AAV‐based Gene Therapy in HIV‐Positive Individuals With Haemophilia
di: Jürgen K. Rockstroh, et al.
Pubblicazione: (2026)

Innovations in Haemostasis Management in China: From Gene Therapy to Novel Rebalancing Strategies
di: Wei Liu, et al.
Pubblicazione: (2026)

Factor VII Padua in Iran: A Study on 150 Patients With Factor VII Deficiency
di: Seyed Mehrab Safdari, et al.
Pubblicazione: (2025)

Recommendations for Psychosocial Support during Gene Therapy: Results From an EAHAD Interdisciplinary Roundtable
di: Lorynn Teela, et al.
Pubblicazione: (2025)

Management of Persons With Haemophilia Requiring Antithrombotic Therapy: A Canadian Modified Delphi Consensus Study
di: Kelsey Uminski, et al.
Pubblicazione: (2025)

Joint and Myofascial Manual Therapy Techniques in Haemophilic Ankle Arthropathy: A Randomized Pilot Study
di: Carlos Truque‐Díaz, et al.
Pubblicazione: (2025)

Research Letter: Patient Attitudes Towards Haemophilia Gene Therapy at a US Haemophilia Treatment Center
di: Callie Berkowitz, et al.
Pubblicazione: (2024)

Heterozygous large deletion mimicking homozygous substitution in MCFD2 in a patient with combined Factor V and Factor VIII deficiency
di: Hamdi Rezigue, et al.
Pubblicazione: (2024)

Recombinant Activated Factor VIIa Combined With Tranexamic Acid Control Haemostasis in Patients With Severe Factor XI Deficiency Undergoing Urological Procedures
di: Neta Sternbach, et al.
Pubblicazione: (2025)

Factor VIII Activity and Factor VIII Inhibitors Can Be Measured Accurately in Plasma Containing Mim8 by Using Specific Chromogenic Assays
di: William Pickering, et al.
Pubblicazione: (2025)

Perceptions and Recommendations Regarding Haemophilia B Gene Therapy: A Multistakeholder View From Patients, Caregivers and Healthcare Professionals
di: Nidhi Bhatt, et al.
Pubblicazione: (2026)

Plasma‐Derived von Willebrand Factor/Factor VIII Concentrate (Haemate P) in von Willebrand Disease: A Systematic Review and Pharmacovigilance Update
di: Carmen Escuriola Ettingshausen, et al.
Pubblicazione: (2025)

Perioperative Outcomes in Factor XI Deficiency: A Systematic Review
di: Zainab Al‐Housni, et al.
Pubblicazione: (2026)

Sleep and Haemophilia–A Case‐Control Analysis of Associated Factors
di: Alexander Schmidt, et al.
Pubblicazione: (2026)

Determining the Impact of Combination Oral Contraceptives on Von Willebrand Factor and Factor VIII in Healthy Patients and Patients With Von Willebrand Disease: A Scoping Review and Meta‐Analysis
di: Eve Justason, et al.
Pubblicazione: (2025)

Health‐Related Quality of Life Among Female Carriers of Haemophilia and Non‐Carriers in a Colombian Population
di: Fabian A. Manzano‐Di Zeo, et al.
Pubblicazione: (2026)

Integrating Next‐Generation Sequencing Into Routine Molecular Diagnosis of Inherited Coagulation Factor Deficiencies: Real‐World Data From Spanish Patients
di: Nina Borràs, et al.
Pubblicazione: (2025)

Estimating the Factor VIII‐Equivalent Activity of Emicizumab Using Global Assays of Haemostasis
di: Daniel Kraemmer, et al.
Pubblicazione: (2025)

The Iron Ladies: Prevalence and Risk Factors of Iron Deficiency in Females With Bleeding Disorders
di: Meghan McCormick, et al.
Pubblicazione: (2025)

Nationwide Study on Factor V Deficiency in China: Clinical Characteristics, Genotype, and Treatment Approaches
di: Yu Yang, et al.
Pubblicazione: (2025)

Factor VIII Antibodies Demonstrate Type I or Type II Kinetics in Acquired Haemophilia A
di: Kirollos Kamel, et al.
Pubblicazione: (2025)

Correction to “Abstract: The Investigation of Frequency of Prothrombin (FII) and Factor Leiden (FV) Mutations in Patients With Haemophilia”
Pubblicazione: (2025)

Non‐surgical correction of knee flexion deformity in persons with haemophilia: A staged multidisciplinary approach
di: Merlyn Tilak, et al.
Pubblicazione: (2024)

Severe Congenital Factor X Deficiency in an Indian Child With a Concomitant Novel ITGA2 Variant
di: Vasant Kumar, et al.
Pubblicazione: (2026)